Top compounds associated with response to MDS2


Feature Type Standardized
Nominal ANOVA
mRNA ML006 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA ML210 CTRPv2 pan-cancer AAC 0.094 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA BEC CTRPv2 pan-cancer AAC 0.2 0.004
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.098 0.004
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.1 0.004
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.099 0.006
Download CSV